Drugs that contain Megestrol Acetate
1. Megace Es patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6592903 | ENDO PHARMS INC | Nanoparticulate dispersions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
Sep, 2020
(3 years ago) | |
| US9101540 | ENDO PHARMS INC | Nanoparticulate megestrol formulations |
Apr, 2024
(2 days from now) | |
| US7101576 | ENDO PHARMS INC | Nanoparticulate megestrol formulations |
Apr, 2024
(2 days from now) | |
| US9107827 | ENDO PHARMS INC | Nanoparticulate megestrol formulations |
Apr, 2024
(2 days from now) | |
| US9101549 | ENDO PHARMS INC | Nanoparticulate megestrol formulations |
Apr, 2024
(2 days from now) | |
| US9040088 | ENDO PHARMS INC | Nanoparticulate megestrol formulations |
Apr, 2024
(2 days from now) | |
Market Authorisation Date: 05 July, 2005
Treatment: Treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids)
Dosage: SUSPENSION;ORAL
How can I launch a generic of MEGACE ES before it's drug patent expiration?
More Information on Dosage
MEGACE ES family patents
